Hearing News Watch

MINNEAPOLIS, MINNESOTA – Amplifon, the parent company of Miracle-Ear and a global leader in hearing care services and solutions, has been recognized in Newsweek’s annual ranking of America’s 200 Most Loved Workplaces®. Amplifon is the only company in the hearing care industry to be included in this prestigious list. The ranking, developed by Newsweek in collaboration with Most Loved Workplaces®

The U.S. Department of Justice (DOJ) has reached a landmark settlement with the Wisconsin Department of Corrections (DOC) to ensure that prisoners with hearing disabilities receive the necessary accommodations while incarcerated. The agreement follows a DOJ investigation under the Americans with Disabilities Act (ADA), which revealed that the Wisconsin DOC had been failing to provide adequate support for inmates with

SOUTH SAN FRANCISCO, CALIFORNIA — Spiral Therapeutics, Inc., a clinical-stage company focused on developing novel therapies for inner ear disorders, announced the successful completion of the Phase 1b/2a clinical trial of SPT-2101 (6% dexamethasone) in Meniere’s disease. Data review of 21 patients showed a significant reduction in vertigo frequency and severity. The study recruited 21 patients across sites in Perth,

Mason Branstrator, a social media influencer and advocate for people with disabilities, continues to provide education and resources on hearing health and adaptive living to his growing online community. After a skiing accident left him paralyzed from the waist down, Branstrator could have retreated from his ambitions. However, his drive to overcome both physical challenges and childhood hearing loss has

FARMINGTON HILLS, MICHIGAN – Attendees of the International Hearing Society (IHS) 2024 Conference & Expo, held in Louisville, Kentucky, embraced the conference theme of “Take the Lead” in record numbers, with attendance increasing by 20% and sponsor engagement rising by 25% compared to last year. The Kentucky Derby-themed event provided participants the opportunity to earn up to 14.5 continuing education

The EUHA held its General Meeting on 25 September 2024, during which members of the EUHA Executive Committee, Auditing Committee, and Council of Honour were elected. The new leadership is now ready to move forward with their term. Beate Gromke was re-elected as President, marking her third term. Eva Keil-Becker will continue as Vice President, and Peter Möckel remains both

The European Union of Hearing Aid Acousticians (EUHA) and the German Hearing Instruments Industry Association (BVHI) continue to advance the International Congress of Hearing Aid Acousticians. A newly introduced feature, the EUHA-Live Area, will include a stage and a designated meeting and networking space, enhancing the connection between the Congress and the Industry Exhibition through spatial arrangement and events. Within

Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat, and prevent hearing loss disorders, announced new positive medical data from its clinical programs, SENS-501 and SENS-401, during a symposium at the 36th World Congress of Audiology (WCA) in Paris, held at CNIT, La Défense, France. The company presented data from

CARLSBAD, CALIFORNIA — Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported that preclinical results with ReSonance (ANP1), the company’s auditory neuronal cell transplant for the treatment of hearing loss, were presented at the 59th Annual Inner Ear Biology Workshop by Ofer Wiser, Ph.D. Senior Scientist, Technological Innovation

EDEN PRAIRIE, MINNESOTA — Starkey has announced that its Chief Technology Officer, Achin Bhowmik, Ph.D., has been appointed as an Industry Representative for the U.S. FDA Digital Health Advisory Committee. The Digital Health Advisory Committee provides expert guidance to the FDA on matters related to the development and regulation of digital health technologies. Dr. Bhowmik’s selection reflects Starkey’s ongoing commitment